GAM Holding’s Kite Pharma, Inc. KITE Stock Holding History

GAM Holding’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-77,651	Closed	-$14M	–	922
2017 Q3	$14M	Buy	77,651 +52,151	+205%	+$7.27M	0.59%	39
2017 Q2	$2.64M	Sell	25,500 -6,300	-20%	-$514K	0.04%	445
2017 Q1	$2.5M	Sell	31,800 -5,000	-14%	-$309K	0.04%	458
2016 Q4	$1.65M	Buy	+36,800	New	+$1.81M	0.03%	532
2016 Q3	–	Sell	-86,800	Closed	-$4.34M	–	994
2016 Q2	$4.34M	Buy	86,800 +43,400	+100%	+$2.13M	0.07%	336
2016 Q1	$1.99M	Buy	43,400 +13,000	+43%	+$630K	0.03%	472
2015 Q4	$1.87M	Buy	30,400 +22,300	+275%	+$1.57M	0.03%	515
2015 Q3	$451K	Buy	+8,100	New	+$509K	0.01%	852

GAM Holding's KITE Position: Q4 2017 in Review

GAM Holding sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 77,651 shares — an estimated $14M sold.

GAM Holding first reported a position in KITE in Q3 2015 and held it in 8 quarters. The position peaked at $14M in Q3 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

GAM Holding reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
GAM Holding sold 77,651 Kite Pharma, Inc. shares in Q4 2017, an estimated $14M.
GAM Holding first reported a position in Kite Pharma, Inc. in Q3 2015 and held it in 8 quarters.
GAM Holding's Kite Pharma, Inc. position peaked at $14M in Q3 2017.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on GAM Holding's 13F filing for Q4 2017, filed 14 Feb 2018.